BACKGROUND: The World Health Organization defines health as complete physical, mental, and social well-being. Chronic diseases impact health-related quality of life (QoL). Health services for ill populations, including end-stage renal disease (ESRD), focus on QoL issues and mental health promotion. Kidney transplantation is the optimal form, but most patients require dialysis, which can be hemodialysis (HD) or peritoneal dialysis (PD). It is believed that choosing the proper modality will help in improving patient's QoL and satisfaction rate. To help patients select the mode of dialysis that best meets their needs while they have ESRD, this study intends to investigate differences in QoL between dialysis modalities. METHODOLOGY: It was a multicenter cross-sectional study conducted in Saudi Arabia, focusing on HD and PD patients in specific hospitals. Data was collected through a specially designed online questionnaire and analyzed with IBM SPSS 29 (IBM Corp. Released 2023. IBM SPSS Statistics for Windows, Version 29.0.2.0 Armonk, NY: IBM Corp). RESULTS: Our study, including 307 dialysis patients in Saudi Arabia, revealed a male predominance (56.0%), primarily aged 45-64 years (43.0%), with 91.5% Saudi nationals. Employment varied (27.4% professionals), and most earned 10,000-20,000 SAR monthly (50.5%). Positive life changes post-dialysis were reported by 98.7%, with 94.5% not requiring post-dialysis absence from work. Incenter HD patients constitute 45.3% while PD patients constitute 54.7% of the study sample. Physical well-being showed significant differences in nausea (p=0.035). Social and emotional well-being exhibited acceptance variations (p=0.012) and coping satisfaction (p=0.014). Linear regression indicated monthly income impact on HD QoL (B=-3.706, p=0.075), while age influenced PD QoL (B=0.113, p=0.927). CONCLUSION: Our study underscores positive life changes and minimal work absence is prevalent among dialysis patients. PD exhibits higher nausea and lower family acceptance. HD participants report greater coping satisfaction. The study reveals nuanced differences in well-being dimensions, contributing insights for tailored interventions and patient-centered care in renal replacement therapies.
health-related quality of lifeperitoneal dialysishemodialysisend-stage renal disease
Journal of Advanced Trends in Medical Research · مجلد 2 (3) · 523-528
Background: Diabetic neuropathy is a common and disabling complication of type 2 diabetes (T2D), often linked to Vitamin B12 deficiency. Despite observed B12 malabsorption in T2D patients, the role of gut microbiota in this process is poorly understood. Methods: We established a novel fecal microbiota transplantation (FMT) model using samples from T2D patients stratified by B12 status and neuropathy severity, transplanted into germ-free mice. We assessed ileal expression of B12 transporters, serum B12 levels and cobalamin-related metabolites. Neuropathy progression was evaluated through nerve conduction studies and histopathological analysis. Microbial composition was analysed through 16S rRNA sequencing, and metabolomic data were obtained using ion mobility-enhanced liquid chromatography-mass spectrometry. Machine learning algorithms integrated microbial and host data to identify predictive patterns and therapeutic targets. Results: FMT from T2D donors with B12 deficiency led to decreased expression of B12 absorption markers and reduced serum B12 levels in recipient mice. These mice showed early signs of neuropathy, confirmed by slowed nerve conduction and structural nerve damage. Specific microbial taxa were significantly associated with altered B12 metabolism and indicators of neuropathy. Multiomics and machine learning analyses revealed key microbial signatures and metabolic pathways involved in B12 dysregulation. Conclusion: Gut microbiota plays a mechanistic role in Vitamin B12 malabsorption and the progression of diabetic neuropathy. This model provides a platform for microbiota-informed diagnostics and targeted interventions in T2D complications.
Journal of Advanced Trends in Medical Research · مجلد 2 (4) · 671-681
Hair loss, or alopecia, encompasses a diverse range of conditions including both cicatricial (scarring) and non-cicatricial (non-scarring) forms, with significant implications for patients’ physical appearance, psychological well-being and overall quality of life. The limitations of traditional therapies such as topical agents, oral medications and hair transplantation have led to increasing interest in regenerative approaches. Amongst these, platelet-rich plasma (PRP) and exosome-based therapies have emerged as promising biologic interventions. PRP, derived from autologous blood, contains a high concentration of platelets rich in growth factors that support hair follicle regeneration, angiogenesis and cellular proliferation. Evidence suggests its potential benefits in various types of hair loss particularly androgenetic alopecia, alopecia areata and telogen effluvium, although standardised protocols, optimal dosing and long-term outcomes remain uncertain. Exosomes are small extracellular vesicles secreted by stem cells that offer a novel cell-free alternative capable of delivering complex molecular signals to modulate inflammation, stimulate follicular stem cells, and promote dermal remodeling. Early findings indicate possible applications across a range of alopecias including chemotherapy-induced hair loss, autoimmune related alopecia and structural hair shaft disorders such as trichorrhexis nodosa and monilethrix. This narrative review provides an updated overview of PRP and exosome-based therapies, outlining their mechanisms of action, clinical applications and current limitations. While both modalities show therapeutic promise, their biologic variability, lack of regulatory standardisation and need for comparative trials highlight critical gaps in evidence. Further research is warranted to establish reproducible treatment protocols and determine long-term efficacy and safety for clinical use.
Journal of Ovarian Research · مجلد 17 (1) · 184-184
Ovarian insufficiency is one of the common reproductive disorders affecting women with limited therapeutic aids. Mesenchymal stem cells have been investigated in such disorders before yet, the exact mechanism of MSCs in ovarian regeneration regarding their epigenetic regulation remains elusive. The current study is to investigate the role of the bone marrow-derived mesenchymal stem cells (BM-MSCs) lncRNA (Neat-1 and Hotair1) and miRNA (mir-21-5p, mir-144-5p, and mir-664-5p) in mitigating ovarian granulosa cell apoptosis as well as searching BM-MSCs in altering the expression of ovarian and hypothalamic IGF-1 - kisspeptin system in connection to HPG axis in a cyclophosphamide-induced ovarian failure rat model. Sixty mature female Sprague Dawley rats were divided into 3 equal groups; control group, premature ovarian insufficiency (POI) group, and POI + BM-MSCs. POI female rat model was established with cyclophosphamide. The result revealed that BM-MSCs and their conditioned media displayed a significant expression level of Neat-1, Hotair-1, mir-21-5p, mir-144-5p, and mir-664-5p. Moreover, BM-MSCs transplantation in POI rats improves; the ovarian and hypothalamic IGF-1 - kisspeptin, HPG axis, ovarian granulosa cell apoptosis, steroidogenesis, angiogenesis, energy balance, and oxidative stress. BM-MSCs expressed higher levels of antiapoptotic lncRNAs and microRNAs that mitigate ovarian insufficiency.
bone marrow mesenchymal stem cellspremature ovarian insufficiencymiR-21miR-144
Type 1 diabetes mellitus (T1DM) was established to be ameliorated by islet transplantation, but the shortage of the transplanted human islet tissue and the use of immunosuppressive drugs to inhibit the rejection of allogeneic grafts make this type of therapy is limited. Nowadays, therapy with stem cells is one of the most promising future treatments. This kind of therapy could have a profound impact on both replacement, as well as regenerative therapies, to improve or even cure various disorders, including diabetes mellitus. Flavonoids have also been shown to possess anti-diabetic effects. Thus, this study aims to evaluate the effectiveness of the bone marrow-derived mesenchymal stem cells (BM-MSCs) and hesperetin in the treatment of a T1DM rat model. T1DM was induced in male Wistar rats that had been starved for 16 h via intraperitoneal injection of STZ at a dose of 40 mg/kg body weight (b.wt.). After 10 days of STZ injection, the diabetic rats were allocated into four groups. The first diabetic animal group was considered a diabetic control, while the other three diabetic animal groups were treated for six weeks, respectively, with hesperetin (given orally at a dose of 20 mg/kg b.wt.), BM-MSCs (injected intravenously at a dose of 1 × 106 cells/rat/week), and their combination (hesperetin and BM-MSCs). The use of hesperetin and BM-MSCs in the treatment of STZ-induced diabetic animals significantly improved the glycemic state, serum fructosamine, insulin and C-peptide levels, liver glycogen content, glycogen phosphorylase, glucose-6-phosphatase activities, hepatic oxidative stress, and mRNA expressions of NF-κB, IL-1β, IL-10, P53, and Bcl-2 in pancreatic tissue. The study suggested the therapy with both hesperetin and BM-MSCs produced marked antihyperglycemic effects, which may be mediated via their potencies to ameliorate pancreatic islet architecture and insulin secretory response, as well as to decrease hepatic glucose output in diabetic animals. The improvement effects of hesperetin and BM-MSCs on the pancreatic islets of diabetic rats may be mediated via their antioxidant, anti-inflammatory, and antiapoptotic actions.
type 1 diabetesbone marrow-derived mesenchymal stem cellshesperetinstreptozotocin-induced diabetes
Objective: Because the poor survival of transplanted cells in a hostile microenvironment limits stem cell therapy, in the current study, we investigated the effect of rapamycin (Rapa)-preactivated autophagy on the survival and homing of transplanted adipose mesenchymal stem cells (ADMSCs) in a rat model of cisplatin (Cis)-induced nephrotoxicity, as well as the possible role of the mTOR/AKT signaling pathway. Materials and methods: In vitro, ADMSCs isolated from rats were treated with 50 nmol/L rapamycin for 2 h, after which the cytoprotective and autophagy-inducing effects of Rapa were investigated. The cis-induced acute nephrotoxicity rat model was constructed in vivo. ADMSCs and Rapa-ADMSCs were administered into the tail vein before Cis therapy. At 3, 7, and 10 days after Cis injection, all animals were euthanized. The renal functions and morphology as well as autophagy response were assessed. Results: The pretreatment of cultured ADMSCs with Rapa caused a significant increase in autophagic activities and lysosome production of the cells, with a significant increase in the secretion of SDF-1, IL-10 and autophagy promoter LC3 and Beclin from these cells, while mTOR/AKT pathways were inhibited. In addition, the transplantation of Rapa-pretreated ADMSCs restored the kidney functions and morphology dramatically. Renal expression of SDF-1 and HIF1 was upregulated, while expression of IL-6, NF-kB and TGF-β1 was downregulated. Conclusions: We concluded that the preactivation of autophagy with Rapa improves the survival and differentiation of the transplanted ADMSCs by inhibiting the mTOR/AKT signaling pathway, which in turn could significantly attenuate the Cis-induced acute renal injury.
BACKGROUND: Liver transplantation remains the only viable therapy for liver failure but has a severely restricted utility. Here, we aimed to decellularize rat livers to form acellular 3D bio-scaffolds suitable for seeding with induced pluripotent cells (iPSCs) as a tool to investigate the role of Wnt/β-catenin signaling in liver development and generation. METHODS: Dissected rat livers were randomly divided into three groups: I (control); II (decellularized scaffolds) and III (recellularized scaffolds). Liver decellularization was established via an adapted perfusion procedure and assessed through the measurement of extracellular matrix (ECM) proteins and DNA content. Liver recellularization was assessed through histological examination and measurement of transcript levels of Wnt/β-catenin pathway, hepatogenesis, liver-specific microRNAs and growth factors essential for liver development. Adult rat liver decellularization was confirmed by the maintenance of ECM proteins and persistence of growth factors essential for liver regeneration. RESULTS: iPSCs seeded rat decellularized livers displayed upregulated transcript expression of Wnt/β-catenin pathway-related, growth factors, and liver specification genes. Further, recellularized livers displayed restored liver-specific functions including albumin secretion and urea synthesis. CONCLUSION: This establishes proof-of-principle for the generation of three-dimensional liver organ scaffolds as grafts and functional re-establishment.
The demand for liver transplantation in the Kingdom of Saudi Arabia (KSA) is associated with the country's high burden of liver disease. Trends in the epidemiology of liver transplantation indications among recipients in KSA have changed over 20 years. Non-alcoholic steatohepatitis has eclipsed the hepatitis C virus in the country due to the effective treatment strategies for HCV. Risk factors for NASH, like type 2 diabetes mellitus, obesity, and hyperlipidemia, are becoming a major concern and a leading indication for liver transplantation in the KSA. There is also a significantly increased prevalence and incidence of genetic adult familial liver diseases in KSA. New immunosuppressive agents and preservation solutions, improved surgical capabilities, and early disease recognition and management have increased the success rate of liver transplant outcome but concerns about the side effects of immunosuppressive therapy can jeopardise long-term survival outcomes. Despite this, indications for liver transplantation continue to increase, resulting in ongoing challenges to maximize the number of potential donors and reduce patient mortality rate while expecting to get transplanted. The Saudi Center of Organ Transplant is the recognized National Organ Donation Agency for transplantation, which renders important support for procurement and allocation of organs. This guidance document aims to help healthcare providers in managing patients in the liver transplant setting.
liver transplantationtransplant indicationsnonalcoholic steatohepatitishepatitis C
International Journal of General Medicine · مجلد Volume 14 · 5711-5718
BACKGROUND: This work endeavored to explore the effect of hypothyroidism on mortality in subjects with HCC who underwent living-donor liver transplantation (LDLT). METHODS: This prospective study included 107 patients with HCC subjected to LDLT, divided into hypothyroid group (n=53) and euthyroid group (n=54). The primary objectives were overall and disease-free survival (DFS). RESULTS: Euthyroid and hypothyroid groups were comparable in all baseline characteristics except the age of patients. Overall survival (OS) of the whole group at 48 months was 68.8%, while the DFS was 60.2%. On univariate analysis, OS was negatively affected by the older age of the patients (p<0.001) or the donor (p<0.001), hypothyroidism (p=0.008), HBV (p=0.029), larger tumor size (p=0.023), and defective Milan criteria (p=0.022). On multivariate analysis, the age of the patients and donors was the independent factor affecting OS. On univariate analysis, DFS was negatively affected by older age of the patients (p < 0.001) or the donor (p=0.005), hypothyroidism (p=0.005), HBV (p=0.019), larger tumor size (p=0.023), and defective Milan criteria (p=0.020). On multivariate analysis, the age of the patients, thyroid status, and Milan criteria were the independent factors affecting DFS. CONCLUSION: Hypothyroidism is a risk factor for worse outcomes in HCC patients after liver transplantation.
Abstract Introduction : Hemorrhagic cystitis (HC) is one of common complications after allogeneic hematopoietic SCT (HSCT) with reported incidence varying from 7 to 70%. Several reports have shown that BK is strongly associated with HC (BK-HC) following HSCT. We conducted an institutional retrospective study to analyze the incidence and clinical factors associated with BK-HC following HSCT. Methods : A total of 517 consecutive patients above the age of 14 years receiving HSCT from 2009 and June 2015 were included in this retrospective analysis and evaluated for HC and urinary BK. HC was defined as documented hematuria of any grade and BK viruria was defined as positive at any level by BKV quantitative PCR testing in urine. Patients were stratified, based on hematuria and urinary BK virus, into the following groups (a) BK virus positive hemorrhagic cystitis (BK+HC), (b) BK virus negative hemorrhagic cystitis (BK-HC) and (c) Non-hemorrhagic cystitis (HC-). Screening for microscopic hematuria was performed only for patients with any kind of urinary symptoms. Results: 479 patients (92.6%) were matched related donor and 308 (60%) were male with a median age of 24 (range 14 to 66). Diagnoses were AML for 195 (38%), ALL for 183 (35%) and bone marrow failure for 44 (8.5%). Conditioning regimen was cyclophosphamide based in 427 (82.6%) patients (97%) versus others in 90 (17.4%) patients. GVHD prophylaxis was CSA/MTX for 456 (88.4%) however, T cell depletion was used in 13%. Peripheral blood stem cells were used for 56% of patients. With a median follow-up of 60 months for survivors (range 2 to 116.5 months), 43 (8%) patients showed BK+HC, 264 (51%) BK- HC while 209 (41%) did not have any hematuria (HC- group). Median time from transplantation to BK+ HC was 67 days (range 7 to 1261 days). Univariate analysis for risk factors of BK+ HC showed male, use of T-cell depletion and AML diagnosis were statistically significant factors. Other factors like age, conditioning regimen, GVHD prophylaxis, stem cell source, mismatched and remission status were not statistically significant. BK+ HC group was associated with higher incidence of other infections like CMV viremia (p=0.01) and fungal infection (p<0.01). Incidence of acute GVHD was 62.8% in BK+ HC group, 43% in HC- BK and 33.3% in HC- group (p=<0.01), suggesting higher incidence of acute GVHD in BK+ HC group. There was no difference in incidence of chronic GVHD. Conclusion: Hematuria following allogeneic bone marrow transplantation occurs in almost half of patients (51%) while BK associated HC develops in 8% of patients. Factors associated with BK+ HC were male gender, use of T-cell depletion and AML diagnosis. BK+HC is usually associated with other infections like CMV viremia and fungal infections. Further studies are needed to minimize or prevent BK+ HC following HSCT especially in high risk group. Disclosures No relevant conflicts of interest to declare.
BK virushemorrhagic cystitisallogeneic hematopoietic stem cell transplantationhematuria
Background Diabetes mellitus (DM) is one of the most prevalent chronic diseases affecting people globally. To date, researchers are still in search for new therapeutic measures that could further improve patients conditions. The aim of this study was to investigate the therapeutic response to injected human umbilical cord blood mesenchymal stem cells (HUCBMSC) in Streptozotocin (STZ) induced diabetic albino rats. Materials and Methods The present study was conducted on three groups of albino rats. The first group (GI, n=25), was the control group in which rats were fed with standard rat diet, Group II and III (n= 25 each) were STZ‐induced diabetic albino rats with and without differentiated HUCBMSC stem cell implantation respectively. Animals were sacrificed on the eleventh week following implantation, and liver biopsies were collected. In addition to hematoxylin and eosin (H&E), liver sections were stained with Prussian blue as well as immunostain using anti‐ human insulin antibodies in order to highlight both the presence and function of the impregnated cells in the liver tissue. Results The H&E stained sections of the rats in GI and GII showed normal liver architecture while animals of GIII showed the presence of cell clusters inside the liver tissue and around central veins. Blue cell clusters were absent in animals of GI and GII when stained with Prussian blue. However, these cell clusters with blue cytoplasm were present in sections from GIII indicating the presence of injected differentiated UCBMSCs (). The sections with antihuman insulin immunostaining of GIII showed clusters of cells within the liver parenchyma and around the central veins indicating that these cells are active and secreting insulin (), while there were no such cells found inside the liver parenchyma of GI and GII (). Conclusion Human UCBMSCs are capable of differentiating into insulin‐secreting cells (IPCs) in vivo when transplanted into the liver of STZ‐induced diabetic albino rats. They were able to secrete insulin and partially control the diabetic status of the rats. However, further research is needed in the field of human UCBMSCs, in the hope that it might be a promising source with potential therapeutic application in diabetics.